Palop L - Search Results

1

[Molecular diagnosis of adult dominant polycystic kidney disease in the Canary Islands].

Torres MJ, Rodríguez Pérez JC, Hernández Socorro CR, Anabitarte A, Caballero A, Vázquez C, Fernández-Burriel M, Pérez Borges P, Palop L. Torres MJ, et al. Among authors: palop l. Nefrologia. 2006;26(6):666-72. Nefrologia. 2006. PMID: 17227243 Free article. Spanish.

2

[Renal protective therapy in diabetic nephropathy. Available evidence].

Rodríguez Pérez JC, Rodríguez Esparragón FJ, Hernández Perera O, Plaza C, Palop L. Rodríguez Pérez JC, et al. Among authors: palop l. Nefrologia. 2001;21 Suppl 3:58-65. Nefrologia. 2001. PMID: 11642209 Free article. Review. Spanish. No abstract available.

3

[Valsartan in patients with arterial hypertension and type 2 diabetes mellitus. The lapaval study].

Rodríguez Pérez JC, Novoa Novoa J, Caballero A, Anabitarte A, Plaza C, Palop L, Rodríguez Esparragón F. Rodríguez Pérez JC, et al. Among authors: palop l. Nefrologia. 2005;25(5):500-8. Nefrologia. 2005. PMID: 16392299 Free article. Clinical Trial. Spanish.

4

Low turnover bone disease is the more common form of bone disease in CAPD patients.

Rodriguez-Perez JC, Plaza C, Torres A, Vega N, Anabitarte A, Fernandez A, Lorenzo V, Hortal L, Palop L. Rodriguez-Perez JC, et al. Among authors: palop l. Adv Perit Dial. 1992;8:376-80. Adv Perit Dial. 1992. PMID: 1361827

5

Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats.

Rodriguez-Perez JC, Losada A, Anabitarte A, Cabrera J, Llobet J, Palop L, Plaza C. Rodriguez-Perez JC, et al. Among authors: palop l. J Pharmacol Exp Ther. 1997 Oct;283(1):336-44. J Pharmacol Exp Ther. 1997. PMID: 9336341

6

Arterial calcification in diabetic patients undergoing CAPD.

Rodríguez-Pérez JC, Vega N, Torres A, Plaza C, Lorenzo V, Fernández A, Hortal L, Palop L. Rodríguez-Pérez JC, et al. Among authors: palop l. Contrib Nephrol. 1991;89:205-13. doi: 10.1159/000419768. Contrib Nephrol. 1991. PMID: 1893728 No abstract available.

7

Percutaneous transluminal angioplasty as best treatment in stenosis of vascular access for hemodialysis.

Rodriguez-Perez JC, Maynar M, Rams A, Plaza C, Vega N, Alamo R, Reyes R, Fernandez A, Palop L. Rodriguez-Perez JC, et al. Among authors: palop l. Nephron. 1989;51(2):192-6. doi: 10.1159/000185284. Nephron. 1989. PMID: 2521697

8

Treatment of renovascular hypertension with percutaneous transluminal angioplasty: experience in Spain.

Rodríguez-Pérez JC, Plaza C, Reyes R, Pulido-Duque JM, Palop L, Ferral H, Maynar M, Castaneda-Zuniga WR. Rodríguez-Pérez JC, et al. Among authors: palop l. J Vasc Interv Radiol. 1994 Jan-Feb;5(1):101-9. doi: 10.1016/s1051-0443(94)71462-7. J Vasc Interv Radiol. 1994. PMID: 8136585

9

Sepsis and death after embolization of host kidneys in a resistant renal hypertension transplanted patient.

Rodríguez-Pérez JC, Maynar M, Palop L, Plaza C, Fernández A, Vega N. Rodríguez-Pérez JC, et al. Among authors: palop l. Nephron. 1988;50(1):75-6. doi: 10.1159/000185128. Nephron. 1988. PMID: 3050575 Free article. No abstract available.

10

Anemia in dialysis: its relation to acquired cystic kidney disease and serum levels of erythropoietin.

Férnandez A, Hortal L, Rodríguez JC, Vega N, Plaza C, Palop L. Férnandez A, et al. Among authors: palop l. Am J Nephrol. 1991;11(1):12-5. doi: 10.1159/000168265. Am J Nephrol. 1991. PMID: 2048573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters